The role of various surfactants on the release of salbutamol from suppositories

Abd-Elbary, 1992, Bioavailability of salbutamol sulphate from different suppository formulation, Egypt. J. Pharm., 33, 1031 Plaxco, 1976, Suppositories, 163 Peter, 1997, 156 Katzung, 1998, 331 1991, 2, 1207 Moolenaar, 1980, Biopharmaceutics of the rectal administration of drugs, Pharm. Int., 7, 144 Fontan, 1991, Enhancing properties of surfactants on the release of carbamazepine from suppositories, Int. J. Pharm., 73, 17, 10.1016/0378-5173(91)90095-6 Margarit, 1992, Myrj 51 as a suppository excipient: influence on pharmaceutical availability and bioavailability of sodium valproate, Int. J. Pharm., 81, 67, 10.1016/0378-5173(92)90044-3 Zein, 1987, Release characteristics and bioavailability of norfloxacin from suppositories bases, Drug Dev. Ind. Pharm., 13, 1973, 10.3109/03639048709068702 Tukker, 2002, Suppository and rectal formulations, 534 Gibaldi, 1970, Mechanisms of surfactant effects on drug absorption, J. Pharm. Sci., 59, 579, 10.1002/jps.2600590502 Rieger, 1988, Surfactants, 1, 285 Moes, 1976, Methodes d'évaluation de l'absorption des médicaments par voie rectate, Labo-Pharma. Tech., 24, 1027 Cooper, 1984, Increased skin permeability of lipophilic molecules, J. Pharm. Sci., 73, 1153, 10.1002/jps.2600730831